Literature DB >> 6459888

Hearing loss and treatment in young Down's syndrome children.

C Cunningham, K McArthur.   

Abstract

Twenty-four home-reared Down's syndrome children aged 9-32 months were assessed by trained audiologists on three separate occasions (summer, autumn and spring 1977-1978). Distraction test procedures were used; all failed to pass the screening test and 80-85% registered as having moderate to profound losses. Seventy-five per cent were categorized as having a conductive loss and some improvements were found over the test sessions as a result of surgical and decongestant treatment. Approximately 50% of the infants had been passed on similar screening procedures by the local health services. The results are discussed in relation to language development and service needs.

Entities:  

Mesh:

Year:  1981        PMID: 6459888     DOI: 10.1111/j.1365-2214.1981.tb00852.x

Source DB:  PubMed          Journal:  Child Care Health Dev        ISSN: 0305-1862            Impact factor:   2.508


  5 in total

1.  Hearing loss in adults with learning disabilities.

Authors:  S Yeates
Journal:  BMJ       Date:  1991-08-24

2.  Acoustic impedance measurement as screening procedure in children: discussion paper.

Authors:  D N Brooks
Journal:  J R Soc Med       Date:  1985-02       Impact factor: 5.344

3.  A cross-sectional analysis of otitis media with effusion in children with Down syndrome.

Authors:  M Maris; M Wojciechowski; P Van de Heyning; An Boudewyns
Journal:  Eur J Pediatr       Date:  2014-05-10       Impact factor: 3.183

4.  Verbal short-term memory deficits in Down syndrome: phonological, semantic, or both?

Authors:  Nancy Raitano Lee; Bruce F Pennington; Janice M Keenan
Journal:  J Neurodev Disord       Date:  2009-09-10       Impact factor: 4.025

5.  MicroRNAs and intellectual disability (ID) in Down syndrome, X-linked ID, and Fragile X syndrome.

Authors:  Wei-Hong Siew; Kai-Leng Tan; Maryam Abbaspour Babaei; Pike-See Cheah; King-Hwa Ling
Journal:  Front Cell Neurosci       Date:  2013-04-15       Impact factor: 5.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.